marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Hoth Therapeutics Financial Ratios 2011-2024 | HOTH
Annual Financial Ratios Hoth Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -0.2 | -0.0 | -3.6 | -5.6 | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.3 | -9.5 | -16.0 | -0.6 | -0.8 | -0.5 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
-3.41 M | -2.34 M | -6.93 M | 24.1 M | 41.8 M | 66.3 K | 49.5 K | - | - | - | - | - | - |
EBITDA per Share |
-2.26 | -9.24 | -15.8 | -0.591 | -0.842 | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.5 | -3.2 | -5.4 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.56 | -0.03 | - | - | - | - | - | - | - | - | ||
P/B |
0.6 | 0.5 | 0.1 | 5.6 | 18.0 | - | - | - | - | - | - | - | - |
P/CF |
-0.6 | -0.3 | -0.0 | -4.1 | -8.5 | - | - | - | - | - | - | - | - |
ROE % |
-89.00 | -222.04 | -144.84 | -154.94 | -321.56 | - | - | - | - | - | - | - | - |
ROA % |
-82.41 | -168.24 | -130.30 | -137.29 | -271.66 | - | - | - | - | - | - | - | - |
ROCE % |
-87.26 | -216.05 | -142.69 | -148.10 | -321.99 | - | - | - | - | - | - | - | - |
Current Ratio |
13.5 | 4.1 | 10.0 | 15.3 | 6.0 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Hoth Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.31 | -0.24 | -0.46 | - | -0.6 | -0.57 | -0.88 | - | -2.05 | -2.16 | -2.68 | - | -3.45 | -0.14 | -0.24 | - | -0.16 | -0.2 | -0.18 | - | -0.17 | -0.13 | -0.12 | - | -0.12 | -0.15 | -0.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | -2.08 | -1.85 | -2.77 | - | -3.4 | -0.14 | -0.24 | - | -0.16 | -0.2 | -0.18 | - | -0.17 | -0.13 | -0.12 | - | -0.12 | -0.15 | -0.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-91.84 | -83.25 | -84.59 | -57.08 | -87.79 | -98.64 | -103.68 | -87.18 | -111.88 | -105.87 | -101.77 | -65.83 | -111.39 | -132.27 | -166.26 | -138.65 | -209.43 | -234.65 | -233.79 | -158.30 | -558.54 | -888.00 | -1327.74 | -1233.31 | -1233.31 | -833.07 | -340.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-83.23 | -74.83 | -74.28 | -49.20 | -75.92 | -85.38 | -91.52 | -77.33 | -99.03 | -94.01 | -90.32 | -60.17 | -100.55 | -119.23 | -148.70 | -122.86 | -182.66 | -202.08 | -199.14 | -133.74 | -256.82 | -320.10 | -426.91 | -379.27 | -379.27 | -256.19 | -104.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-92.12 | -83.60 | -83.17 | -55.57 | -86.74 | -98.00 | -101.32 | -85.41 | -109.79 | -102.99 | -101.80 | -65.08 | -111.72 | -133.99 | -168.84 | -139.90 | -210.87 | -235.20 | -233.94 | -158.49 | -558.73 | -888.00 | -1327.74 | -1233.31 | -1233.31 | -833.07 | -340.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
10.2 | 14.5 | 12.9 | 13.5 | 7.7 | 6.1 | 8.4 | 4.1 | 7.7 | 11.9 | 8.4 | 10.0 | 8.2 | 12.4 | 20.1 | 8.8 | 8.8 | 8.8 | 8.8 | 6.4 | 6.4 | 6.4 | 6.4 | 1.4 | 1.4 | 1.4 | 1.4 | 24.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency